Etrolizumab (Anti-Integrin a4b7) (ITGA4 & ITGB7)

Etrolizumab (Anti-Integrin a4b7) (ITGA4 & ITGB7)  is a gut‐selective humanized monoclonal antibody targets β7 integrins with a potential to treat inflammatory bowel disease (IBD). MW: 144.3 KD.

• Supplier: Selleck Chemicals
• Product #: A2856
• Sku #: A2856-1mg*25